X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA STRIDES SHASUN LTD ELDER PHARMA/
STRIDES SHASUN LTD
 
P/E (TTM) x -0.2 15.3 - View Chart
P/BV x 0.1 1.8 5.7% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ELDER PHARMA   STRIDES SHASUN LTD
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
STRIDES SHASUN LTD
Mar-17
ELDER PHARMA/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs3801,275 29.8%   
Low Rs188918 20.5%   
Sales per share (Unadj.) Rs491.2389.6 126.1%  
Earnings per share (Unadj.) Rs-3.228.0 -11.4%  
Cash flow per share (Unadj.) Rs14.448.9 29.5%  
Dividends per share (Unadj.) Rs04.50 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs376.5303.1 124.2%  
Shares outstanding (eoy) m20.5489.42 23.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.62.8 20.5%   
Avg P/E ratio x-89.339.2 -227.7%  
P/CF ratio (eoy) x19.722.4 87.9%  
Price / Book Value ratio x0.83.6 20.9%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m5,83398,036 6.0%   
No. of employees `000NA5.8 0.0%   
Total wages/salary Rs m2,1795,881 37.1%   
Avg. sales/employee Rs ThNM6,005.9-  
Avg. wages/employee Rs ThNM1,014.0-  
Avg. net profit/employee Rs ThNM431.2-  
INCOME DATA
Net Sales Rs m10,08934,834 29.0%  
Other income Rs m2571,686 15.2%   
Total revenues Rs m10,34636,520 28.3%   
Gross profit Rs m-7926,428 -12.3%  
Depreciation Rs m3611,872 19.3%   
Interest Rs m2,7562,269 121.5%   
Profit before tax Rs m-3,6533,973 -91.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m04 0.0%   
Extraordinary Inc (Exp) Rs m3,713-1,006 -369.2%   
Tax Rs m125470 26.6%   
Profit after tax Rs m-652,501 -2.6%  
Gross profit margin %-7.818.5 -42.5%  
Effective tax rate %-3.411.8 -29.0%   
Net profit margin %-0.67.2 -9.0%  
BALANCE SHEET DATA
Current assets Rs m9,24038,165 24.2%   
Current liabilities Rs m9,99830,402 32.9%   
Net working cap to sales %-7.522.3 -33.7%  
Current ratio x0.91.3 73.6%  
Inventory Days Days4677 59.9%  
Debtors Days Days60104 57.4%  
Net fixed assets Rs m10,12437,639 26.9%   
Share capital Rs m206894 23.0%   
"Free" reserves Rs m5,58226,210 21.3%   
Net worth Rs m7,73427,105 28.5%   
Long term debt Rs m4,88916,377 29.9%   
Total assets Rs m22,88281,168 28.2%  
Interest coverage x-0.32.8 -11.8%   
Debt to equity ratio x0.60.6 104.6%  
Sales to assets ratio x0.40.4 102.7%   
Return on assets %11.85.9 200.1%  
Return on equity %-0.89.2 -9.2%  
Return on capital %22.312.1 185.1%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30713,465 2.3%   
Fx outflow Rs m1254,076 3.1%   
Net fx Rs m1819,389 1.9%   
CASH FLOW
From Operations Rs m11,7542,881 407.9%  
From Investments Rs m-561-7,051 7.9%  
From Financial Activity Rs m-6,7623,382 -199.9%  
Net Cashflow Rs m4,432-788 -562.7%  

Share Holding

Indian Promoters % 39.6 27.7 143.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 37.8 19.8%  
FIIs % 16.8 8.6 195.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 25.9 139.4%  
Shareholders   16,479 56,241 29.3%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS